Abstract
Cells of the innate immune system secrete cytokines early in immune responses that guide maturing T helper (Th) cells along appropriate lineages. This study investigates the role of cytokine networks, bridging the innate and acquired immune systems, in the pathogenesis of an organ specific autoimmune disease. Experimental allergic encephalomyelitis (EAE), a demyelinating disease of the central nervous system, is widely used as an animal model for multiple sclerosis. We demonstrate that interleukin (IL)-12 is essential for the generation of the autoreactive Th1 cells that induce EAE, both in the presence and absence of interferon γ. The disease-promoting effects of IL-12 are antagonized by IL-10 produced by an antigen nonspecific CD4+ T cell which, in turn, is regulated by the endogenous production of IL-12. This unique immunoregulatory circuit appears to play a critical role in controlling Th cell differentiation and provides a mechanism by which microbial triggers of the innate immune system can modulate autoimmune disease.
References
83
Referenced
356
10.1146/annurev.iy.07.040189.001045
/ Annu Rev Immunol / Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties by Mosmann (1989)10.1146/annurev.iy.10.040192.002125
/ Annu Rev Immunol / Regulation of autoimmunity to parasites and T cell-derived cytokines by Sher (1992)10.1016/0167-5699(95)80068-9
/ Immunol Today / Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases by Liblau (1995)10.1146/annurev.iy.08.040190.003051
/ Annu Rev Immunol / The T lymphocyte in experimental allergic encephalomyelitis by Zamvil (1990)10.2337/diab.43.2.197
/ Diabetes / Islet-specific T-cell clones from the NOD mouse respond to β-granule antigen by Bergman (1994)10.4049/jimmunol.138.4.1092
/ J Immunol / Transfer of experimental autoimmune thyroiditis with T cell clones by Romball (1987)10.1073/pnas.92.11.4823
/ Proc Natl Acad Sci USA / Administration of interleukin-12 in combination with type ii collagen induces severe arthritis in DBA/1 mice by Germann (1995)10.1006/cimm.1997.1121
/ Cell Immunol / Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis by Xu (1997){'key': '2023072915310963000_B9', 'first-page': '1120', 'article-title': "Cytolytic T cells with Th1-like cytokine profiles predominate in retroorbital lymphocytic infiltrates of Graves' opthalmopathy", 'volume': '77', 'author': 'de Carli', 'year': '1993', 'journal-title': 'J Clin Endocrinol Metab'}
/ J Clin Endocrinol Metab / Cytolytic T cells with Th1-like cytokine profiles predominate in retroorbital lymphocytic infiltrates of Graves' opthalmopathy by de Carli (1993)10.1002/(SICI)1097-4547(19960815)45:4<322::AID-JNR1>3.0.CO;2-B
/ J Neurosci Research / Review: cytokines and the pathogenesis of multiple sclerosis by Navikas (1996)10.1073/pnas.91.18.8562
/ Proc Natl Acad Sci USA / Divergent T cell cytokine patterns in inflammatory arthritis by Simon (1994)10.1001/archopht.1997.01100150522013
/ Arch Ophthamol / Immunologic mechanisms of uveitis. New targets for immunomodulation by Whitcup (1997)10.1016/0167-5699(95)80006-9
/ Immunol Today / The role of IL-12 in the induction of organ-specific autoimmune diseases by Trembleau (1995)10.1084/jem.179.5.1405
/ J Exp Med / Th2 cells: help for helminths by Locksley (1994)10.1016/0167-5699(91)90034-Q
/ Immunol Today / Th2 cells in systemic autoimmunity by Goldman (1991)10.1084/jem.179.2.589
/ J Exp Med / Regulatory interactions between CD45RBhigh and CD45RBlow CD4+T cells are important for the balance between protective and pathogenic cell-mediated immunity by Powrie (1994)10.1016/1074-7613(94)90045-0
/ Immunity / Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+T cells by Powrie (1994)10.1126/science.7761837
/ Science / T helper cell subsets in insulin-dependent diabetes by Katz (1995)10.1002/eji.1830231208
/ Eur J Immunol / Th2 activated cells prevent experimental autoimmune uveoretinitis, a Th1-dependent autoimmune disease by Saoudi (1993)10.4049/jimmunol.155.8.4052
/ J Immunol / Self-antigen–induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2-mediated suppression of autoimmune disease by Cua (1995)10.1016/0008-8749(89)90117-2
/ Cell Immunol / Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphocyte subtype by Ando (1989)10.1084/jem.177.1.57
/ J Exp Med / Surface expression of α4 integrin by CD4 T cells is required for their entry into brain parenchyma by Baron (1993)10.1093/intimm/2.6.539
/ Intern Immunol / Lymphotoxin and tumor necrosis-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogencity by Powell (1990)10.4049/jimmunol.155.10.5011
/ J Immunol / Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced by effector Th1 cells by Khoruts (1995)10.1038/379343a0
/ Nature / Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein by Brocke (1996)10.1016/1074-7613(95)90169-8
/ Immunity / An altered peptide ligand mediates immune deviation and prevents experimental autoimmune encephalomyelitis by Nicholson (1995)10.1126/science.7520605
/ Science / Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis by Chen (1994)10.1016/0165-5728(93)90194-4
/ J Neuroimmunol / Encephalitogenic Th1 T cells are inhibited by Th2 cells with related peptide specificity: relative roles of interleukin (IL)-4 and IL-10 by Van der Veen (1993)10.4049/jimmunol.149.7.2496
/ J Immunol / Analysis of cytokine mRNA expression in the central nervous system of mice with experimental allergic encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery by Kennedy (1992)10.1016/0165-5728(95)00100-G
/ J Neuroimmunol / Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor alpha and tumor necrosis factor beta by Issazadeh (1995)10.1016/0165-5728(96)00076-8
/ J Neuroimmunol / Cytokines in relapsing experimental allergic encephalomyelitis in DA rats: persistent mRNA expression of proinflammatory cytokines and absent expression of interleukin-10 and transforming factor-beta by Issazadeh (1996)10.1084/jem.172.4.1193
/ J Exp Med / An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis by Ruddle (1990)10.1002/ana.410300510
/ Ann Neurol / Anti–tumor necrosis factor therapy abrogates autoimmune demyelination by Selmaj (1991)10.1016/S0165-5728(96)00183-X
/ J Neuroimmunol / TNF-α receptor fusion protein prevents experimental autoimmune encephalomyelitis and demyelination in Lewis rats: an overview by Klinkert (1997)10.1016/0165-5728(94)00139-F
/ J Neuroimmunol / Prevention of chronic relapsing autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I by Selmaj (1995)10.1073/pnas.92.8.3601
/ Proc Natl Acad Sci USA / Prevention of autoimmune damage in non-human primates by a cAMP specific phosphodiesterase inhibitor by Genain (1995)10.1038/nm0395-244
/ Nat Med / The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis by Sommers (1995)10.1002/eji.1830251108
/ Eur J Immunol / Staphylococcal enterotoxin B and tumor-necrosis factor-α-induced relapses of experimental allergic encephalomyelitis: protection by transforming growth factor-β and interleukin-10 by Crisi (1995)10.1084/jem.180.5.1961
/ J Exp Med / Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease by Racke (1994)10.1002/eji.1830240629
/ Eur J Immunol / Interleukin-10 prevents experimental autoimmune encephalomyelitis in rats by Rott (1994)10.1084/jem.185.9.1711
/ J Exp Med / Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis by Shaw (1997)10.1084/jem.186.1.159
/ J Exp Med / Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells by Mathisen (1997)10.4049/jimmunol.140.5.1506
/ J Immunol / Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-γ by Billiau (1988)10.1016/0165-5728(92)90042-J
/ J Neuroimmunol / Effect of anti-interferon-γ and anti–interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse by Duong (1992)10.1016/0165-5728(94)90069-8
/ J Neuroimmunol / Effect of anti–IFN-γ monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains by Duong (1994)10.1002/eji.1830261019
/ Eur J Immunol / Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: enhancement by monoclonal antibodies against interferon-γ by Heremans (1996)10.3109/08916939309014645
/ Autoimmunity / Monoclonal anti-γ interferon antibodies enhance experimental allergic encephalomyelitis by Lublin (1993)10.1111/j.1365-2249.1990.tb03315.x
/ Clin Exp Immunol / Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-γ in Lewis rats by Voorthuis (1990)10.4049/jimmunol.156.1.5
/ J Immunol / Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE) by Ferber (1996)10.1002/eji.1830260735
/ Eur J Immunol / Interferon-γ confers resistance to experimental allergic encephalomyelitis by Krakowski (1996)10.4049/jimmunol.157.8.3223
/ J Immunol / IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis by Willenborg (1996)10.1084/jem.185.12.2177
/ J Exp Med / Tumor necrosis factor α and lymphotoxin α are not required for induction of acute experimental autoimmune encephalomyelitis by Frei (1997)10.1093/intimm/9.5.799
/ Intern Immunol / Experimental autoimmune encephalomyelitis in IL-4–deficient mice by Liblau (1997)10.1084/jem.186.2.307
/ J Exp Med / Myelin basic protein– specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from disease by Lafaille (1997)10.1084/jem.186.2.299
/ J Exp Med / T helper 2 (Th2) cells induce pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice by Pakala (1997)10.1016/S1074-7613(00)80413-6
/ Immunity / IL-12 deficient mice are defective in IFN-γ production and type 1 cytokine responses by Magram (1996)10.1146/annurev.iy.13.040195.001343
/ Annu Rev Immunol / Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity by Trinchieri (1995)10.1016/S0952-7915(97)80154-9
/ Curr Opin Immunol / Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-γ) by Trinchieri (1997)10.1002/eji.1830220314
/ Eur J Immunol / Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10 by O'Garra (1992)10.1126/science.272.5258.50
/ Science / The instructive role of innate immunity in the acquired immune response by Fearon (1996)10.1016/S0952-7915(97)80152-5
/ Curr Opin Immunol / Innate immunity: impact on the adaptive immune response by Medzhitov (1997)10.1084/jem.184.2.771
/ J Exp Med / IL-12 unmasks latent autoimmune disease in resistant mice by Segal (1996)10.4049/jimmunol.158.11.5087
/ J Immunol / Microbial products induce autoimmune disease by an IL-12 dependent pathway by Segal (1997)10.1084/jem.181.1.381
/ J Exp Med / Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12 by Leonard (1995)10.1084/jem.181.2.817
/ J Exp Med / Interleukin 12 induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice by Trembleau (1995)10.4049/jimmunol.145.9.2938
/ J Immunol / Isolation of monoclonal antibodies specific for IL-4, IL-5, IL-6, and a new Th2-specific cytokine (IL-10), cytokine synthesis inhibitory factor, by using a solid phase radioimmunoadsorbant assay by Mosmann (1990)10.1146/annurev.iy.12.040194.003223
/ Annu Rev Immunol / Acquisition of lymphokine-producing phenotype by CD4+T cells by Seder (1994)10.4049/jimmunol.148.11.3433
/ J Immunol / Cloning and expression of murine IL-12 by Schoenhaut (1992)10.4049/jimmunol.157.9.4045
/ J Immunol / In the absence of endogenous IFN-γ, mice develop unimpaired IL-12 responses to Toxoplasma gondiiwhile failing to control acute infection by Scharton-Kersten (1996)10.1084/jem.186.1.39
/ J Exp Med / Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice infected with mycobacterium tuberculosis by Cooper (1997)10.4049/jimmunol.152.4.1883
/ J Immunol / Neutralization of IL-12 decreases resistance to Listeriain SCID and C.B-17 mice. Reversal by IFN-gamma by Tripp (1994)10.4049/jimmunol.152.3.1047
/ J Immunol / Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection by Morris (1994)10.1073/pnas.91.26.12932
/ Proc Natl Acad Sci USA / Interferon-γ–independent effects of interleukin 12 administered during acute or established infection due to Leishmania major. by Wang (1994)10.1084/jem.185.7.1231
/ J Exp Med / Intracellular antimicrobial activity in the absence of interferon-γ: effect of interleukin-12 in experimental visceral leishmaniasis in interferon-γ gene-disrupted mice by Taylor (1997)10.1002/eji.1830260722
/ Eur J Immunol / Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania majorand mount a polarized Th2 cell response by Mattner (1996)10.1016/S0952-7915(97)80151-3
/ Curr Opin Immunol / Innate pathways that control acquired immunity by Bendelac (1997)10.1126/science.270.5243.1845
/ Science / Role of NK1.1+T cells in a Th2 response and in Immunoglobulin E production by Yoshimoto (1995)10.1126/science.7538697
/ Science / CD1 recognition by mouse NK1+T lymphocytes by Bendelac (1995)10.1172/JCI118861
/ J Clin Invest / Enterocolitis and colon cancer in interleukin-10–deficient mice are associated with abberant cytokine production and CD4+Th1-like responses by Berg (1996)10.4049/jimmunol.157.2.798
/ J Immunol / In the absence of IL-10, mice acutely infected with Toxoplasmosis gondii succumb to a lethal immune response dependent on CD4+T cells and accompanied by overproduction of IL-12, IFN-γ and TNF-α by Gazzinelli (1996)10.1084/jem.183.4.1777
/ J Exp Med / A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease by Yu (1996)10.1084/jem.182.1.75
/ J Exp Med / Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis by McRae (1995)10.1172/JCI119331
/ J Clin Invest / Diversity and plasticity of self recognition during the development of multiple sclerosis by Tuohy (1997)
Dates
Type | When |
---|---|
Created | 23 years, 1 month ago (July 26, 2002, 12:49 p.m.) |
Deposited | 2 years, 1 month ago (July 29, 2023, 11:32 a.m.) |
Indexed | 1 month ago (Aug. 2, 2025, 1:23 a.m.) |
Issued | 27 years, 6 months ago (Feb. 16, 1998) |
Published | 27 years, 6 months ago (Feb. 16, 1998) |
Published Online | 27 years, 6 months ago (Feb. 16, 1998) |
Published Print | 27 years, 6 months ago (Feb. 16, 1998) |
@article{Segal_1998, title={An Interleukin (IL)-10/IL-12 Immunoregulatory Circuit Controls Susceptibility to Autoimmune Disease}, volume={187}, ISSN={1540-9538}, url={http://dx.doi.org/10.1084/jem.187.4.537}, DOI={10.1084/jem.187.4.537}, number={4}, journal={The Journal of Experimental Medicine}, publisher={Rockefeller University Press}, author={Segal, Benjamin M. and Dwyer, Bonnie K. and Shevach, Ethan M.}, year={1998}, month=feb, pages={537–546} }